肿瘤系列三EGFRm肺癌ADC和双抗领衔EGFR敏感突变三代TKIs耐药后和1LNSCLC，20ins小分子竞争激烈
informs·2024-07-25 03:55
Summary of Conference Call Transcript Company or Industry Involved - The document does not specify a particular company or industry as it begins with a free statement. Core Points and Arguments - No core points or arguments are provided in the content. Other Important but Possibly Overlooked Content - The document does not contain any additional important information.